Table 5. Baseline angiographic characteristics after propensity score matching.
| Clopidogrel | Prasugrel/Ticagrelor | P | |
|---|---|---|---|
| (n = 268) | (n = 268) | ||
| Mono-vessel disease, n (%) | 131 (48.9) | 136 (50,8) | 0.73 |
| Dual-vessel disease, n (%) | 81 (30.2) | 86 (32,1) | 0.71 |
| Three-vessel disease, n (%) | 56 (20.9) | 46 (17,2) | 0.32 |
| LAD, n (%) | 160 (59.7) | 165 (61.6) | 0.72 |
| CX, n (%) | 83 (31.1) | 79 (29.5) | 0.71 |
| RCA, n (%) | 143 (53.4) | 131 (48.9) | 0.34 |
| Left main coronary artery, n (%) | 13 (4.8) | 10 (3.7) | 0.67 |
| Bifurcation n (%) | 20 (7.5) | 4 (1.5) | 0.0012 |
| Total stent's length (mm) | 20 +/− 14.9 (15–122) | 34 +/− 22 (18–188) | 0.0016 |
| Stent's diameter (mm) | 3 +/− 0.5 (3–4.5) | 3.0 +/− 0.8 (2.8–5) | 0.64 |
| DES | 133 (49.6) | 247 (92.5) | 0.0001 |
Values are n +/− median (range) or n (%)
LAD = left anterior descending artery; CX = circumflex artery; RCA = right coronary artery